Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

LDH and melanoma.

Finck SJ, Giuliano AE, Morton DL.

Cancer. 1983 Mar 1;51(5):840-3.

3.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
4.

Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.

Minor DR, Moore D, Kim C, Kashani-Sabet M, Venna SS, Wang W, Boasberg P, O'Day S.

Oncologist. 2009 Oct;14(10):995-1002. doi: 10.1634/theoncologist.2009-0083. Epub 2009 Sep 23.

5.

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma.

Bánfalvi T, Boldizsár M, Gergye M, Gilde K, Kremmer T, Ottó S.

Pathol Oncol Res. 2002;8(3):183-7. Epub 2003 Jan 6.

6.

Efficacy of peroperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast.

Clark CP 3rd, Foreman ML, Peters GN, Cheek JH, Sparkman RS.

Surg Gynecol Obstet. 1988 Dec;167(6):510-4.

PMID:
3055370
7.

Serum S100beta protein as a marker of disease activity in patients with malignant melanoma.

Mohammed MQ, Abraha HD, Sherwood RA, MacRae K, Retsas S.

Med Oncol. 2001;18(2):109-20.

PMID:
11778756
8.

Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.

Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG.

Ann Surg Oncol. 2008 Aug;15(8):2206-14. doi: 10.1245/s10434-008-9985-z. Epub 2008 May 30.

PMID:
18512102
9.

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.

Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.

Cancer. 1999 Dec 1;86(11):2252-8.

PMID:
10590365
10.

An evaluation of postoperative follow-up tests in colon cancer patients treated for cure.

Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA.

Oncology. 1997 Jul-Aug;54(4):287-92.

PMID:
9216852
11.

Prognostic factors in 1,521 melanoma patients with distant metastases.

Barth A, Wanek LA, Morton DL.

J Am Coll Surg. 1995 Sep;181(3):193-201.

PMID:
7670677
12.

Evaluation of staging workup in malignant melanoma.

Khansur T, Sanders J, Das SK.

Arch Surg. 1989 Jul;124(7):847-9.

PMID:
2742488
13.

Stage-IV melanoma and pulmonary metastases: factors predictive of survival.

Neuman HB, Patel A, Hanlon C, Wolchok JD, Houghton AN, Coit DG.

Ann Surg Oncol. 2007 Oct;14(10):2847-53. Epub 2007 Aug 7.

PMID:
17680317
14.

The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.

Venkitaraman R, Johnson B, Huddart RA, Parker CC, Horwich A, Dearnaley DP.

BJU Int. 2007 Jul;100(1):30-2.

15.

Surgery for melanoma metastatic to the gastrointestinal tract.

Agrawal S, Yao TJ, Coit DG.

Ann Surg Oncol. 1999 Jun;6(4):336-44.

PMID:
10379853
16.

Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma.

Hamberg AP, Korse CM, Bonfrer JM, de Gast GC.

Melanoma Res. 2003 Feb;13(1):45-9.

PMID:
12569284
17.

Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.

Stokkel MP, van Eck-Smit BL, Zwinderman AH, Willems LN, Pauwels EK.

J Cancer Res Clin Oncol. 1998;124(3-4):215-9.

PMID:
9619749
18.

Screening for metastatic malignant melanoma of the uvea revisited.

Eskelin S, Pyrhönen S, Summanen P, Prause JU, Kivelä T.

Cancer. 1999 Mar 1;85(5):1151-9.

PMID:
10091801
19.

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.

Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG; Oblimersen Melanoma Study Group.

J Clin Oncol. 2006 Oct 10;24(29):4738-45. Epub 2006 Sep 11.

PMID:
16966688
20.

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).

Agarwala SS, Keilholz U, Gilles E, Bedikian AY, Wu J, Kay R, Stein CA, Itri LM, Suciu S, Eggermont AM.

Eur J Cancer. 2009 Jul;45(10):1807-14. doi: 10.1016/j.ejca.2009.04.016. Epub 2009 May 4.

PMID:
19419855

Supplemental Content

Support Center